INFLAMMOPHARMACOLOGY 期刊简介

INFLAMMOPHARMACOLOGY
英文简介:

Inflammopharmacology is the official publication of the Gastrointestinal Section of the International Union of Basic and Clinical Pharmacology (IUPHAR) and the Hungarian Experimental and Clinical Pharmacology Society (HECPS). Inflammopharmacology publishes papers on all aspects of inflammation and its pharmacological control emphasizing comparisons of (a) different inflammatory states, and (b) the actions, therapeutic efficacy and safety of drugs employed in the treatment of inflammatory conditions. The comparative aspects of the types of inflammatory conditions include gastrointestinal disease (e.g. ulcerative colitis, Crohn's disease), parasitic diseases, toxicological manifestations of the effects of drugs and environmental agents, arthritic conditions, and inflammatory effects of injury or aging on skeletal muscle. The journal has seven main interest areas:

-Drug-Disease Interactions - Conditional Pharmacology - i.e. where the condition (disease or stress state) influences the therapeutic response and side (adverse) effects from anti-inflammatory drugs. Mechanisms of drug-disease and drug disease interactions and the role of different stress states
-Rheumatology - particular emphasis on methods of measurement of clinical response effects of new agents, adverse effects from anti-rheumatic drugs
-Gastroenterology - with particular emphasis on animal and human models, mechanisms of mucosal inflammation and ulceration and effects of novel and established anti-ulcer, anti-inflammatory agents, or antiparasitic agents
-Neuro-Inflammation and Pain - model systems, pharmacology of new analgesic agents and mechanisms of neuro-inflammation and pain
-Novel drugs, natural products and nutraceuticals - and their effects on inflammatory processes, especially where there are indications of novel modes action compared with conventional drugs e.g. NSAIDs
-Muscle-immune interactions during inflammation [...]

中文简介:(来自Google、百度翻译)

炎症药理学是国际基础和临床药理学联合会 (IUPHAR) 和匈牙利实验和临床药理学学会 (HECPS) 的胃肠道部分的官方出版物。炎症药理学发表有关炎症及其药理控制的所有方面的论文,着重比较 (a) 不同的炎症状态,以及 (b) 用于治疗炎症性疾病的药物的作用,治疗功效和安全性。炎症性疾病类型的比较方面包括胃肠道疾病 (例如溃疡性结肠炎,克罗恩氏病),寄生虫病,药物和环境因子作用的毒理学表现,关节炎疾病以及损伤或衰老对骨骼肌的炎症作用。该杂志有七个主要的兴趣领域:
-药物-疾病相互作用-条件药理学-即条件 (疾病或压力状态) 影响抗炎药的治疗反应和副作用 (不良)。药物-疾病和药物疾病相互作用的机制以及不同压力状态的作用
-风湿病学-特别强调新药物的临床反应效果的测量方法,抗风湿药的不良反应
-胃肠病学-特别强调动物和人类模型,粘膜炎症和溃疡的机制以及新型和已建立的抗溃疡,抗炎剂或抗寄生虫剂的作用
-神经炎症和疼痛模型系统,新型镇痛剂的药理学以及神经炎症和疼痛的机制
-新药,天然产品和营养保健品-以及它们对炎症过程的影响,尤其是与常规药物相比有新模式作用的迹象,例如NSAIDs
-炎症过程中的肌肉-免疫相互作用 [...]

期刊ISSN
0925-4692
影响指数
4.428
最新CiteScore值
6.10 查看CiteScore评价数据
最新自引率
3.30%
官方指定润色网址
https://www.deeredit.com/?type=ss1
投稿语言要求

Improve the quality of the paper, eliminate grammar and spelling errors, increase readability, ensure accurate communication of viewpoints, enhance academic reputation, and increase the chances of the paper being accepted.

建议点击这个网址:https://www.deeredit.com/?type=ss2,资深审稿专家为您评估稿件质量,提供针对性改进建议,最终可助您极大提升目标期刊录用率

期刊官方网址

hot

https://www.peipusci.com/?type=9
杂志社征稿网址

hot

https://www.peipusci.com/?type=10
通讯地址
PICASSOPLATZ 4, BASEL, SWITZERLAND, 4052
偏重的研究方向(学科)
IMMUNOLOGYTOXICOLOGY-TOXICOLOGY
出版周期
出版年份
1991
出版国家/地区
NETHERLANDS
是否OA
No
SCI期刊coverage
Science Citation Index Expanded(科学引文索引扩展)
NCBI查询
PubMed Central (PMC)链接 全文检索(pubmed central)
INFLAMMOPHARMACOLOGY 期刊中科院JCR 评价数据
最新中科院JCR分区
大类(学科)
小类(学科)
综述期刊
医学
IMMUNOLOGY(免疫学)3区 TOXICOLOGY(毒理学)2区
最新的影响因子
4.428
最新公布的期刊年发文量
年度总发文量 研究类文章占比
146 81.51%
总被引频次 45
影响因子趋势图
近年的影响因子趋势图(整体平稳趋势)

2022年预警名单预测最新

INFLAMMOPHARMACOLOGY 期刊CiteScore评价数据
最新CiteScore值
6.10
年文章数 146
SJR
0.945
SNIP
1.303
CiteScore排名
序号 类别(学科) 排名 百分位
1 Medicine Pharmacology (medical) #47/246
2 Medicine Pharmacology #76/297
3 Medicine Immunology #83/202
CiteScore趋势图
CiteScore趋势图
INFLAMMOPHARMACOLOGY 相关期刊推荐
本刊同领域相关期刊
期刊名称 IF值
VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY 2.026
AIDS 4.135
APMIS 3.173
VACCINE 3.605
BIODRUGS 5.749
IMMUNITY 31.428
LYMPHOLOGY 1.273
Lancet HIV 12.639
AIDS REVIEWS 2.475
本刊同分区等级的相关期刊
期刊名称 IF值
VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY 2.026
VACCINE 3.605
AIDS REVIEWS 2.475
AUTOIMMUNITY 2.787
TUBERCULOSIS 3.1
IMMUNOBIOLOGY 3.113
Immunotherapy 4.154
BMC IMMUNOLOGY 3.579
IMMUNOLOGY LETTERS 3.648
INFLAMMOPHARMACOLOGY 投稿经验(由下方点评分析获得,0人参与,2234人阅读)
投稿录用比例: 0.001620
审稿速度: 暂无
分享者 点评内容
没有更多了~
Copyright © 2014-2019 晟斯医学 All Rights Reserved. 备案号:苏ICP备11037034号-5 版权所有:南京孜文信息咨询有限公司